Institute of Pathology, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.
Medical Faculty Mannheim, Medical Research Center, Heidelberg University, Mannheim, Germany.
Front Immunol. 2020 Apr 16;11:664. doi: 10.3389/fimmu.2020.00664. eCollection 2020.
A unique feature of thymomas is their unrivaled frequency of associated myasthenia gravis (MG). Previous studies reported that MG+ thymomas contain a larger number of mature "pre-emigrant" CD4+ T cells than MG- thymomas and that most thymomas do not contain AIRE expressing cells irrespective of MG status. These findings suggest that CD4+ T cells that mature inside the abnormal microenvironment of thymomas and egress to the blood are critical to the development of thymoma-associated MG (TAMG) irrespective of thymoma histotype. However, underlying mechanisms have remained enigmatic. To get hints to mechanisms underlying TAMG, we pursue three hypotheses: (i) Functional pathways with metabolic and immunological relevance might be differentially expressed in TAMG(+) compared to TAMG(-) thymomas; (ii) differentially enriched pathways might be more evident in immature lymphocyte-poor (i.e., tumor cell/stroma-rich) thymoma subgroups; and (iii) mechanisms leading to TAMG might be different among thymoma histological subtypes. To test these hypotheses, we compared the expression of functional pathways with potential immunological relevance ( = 380) in relation to MG status separately in type AB and B2 thymomas and immature lymphocyte-rich and lymphocyte-poor subgroups of these thymoma types using the TCGA data set. We found that <10% of the investigated pathways were differentially upregulated or downregulated in MG+ compared to MG- thymomas with significant differences between AB and B2 thymomas. The differences were particularly evident, when epithelial cell/stroma-rich subsets of type AB and B2 thymomas were analyzed. Unexpectedly, some MG-associated pathways that were significantly upregulated in AB thymomas were significantly downregulated in B2 thymomas, as exemplified by the oxidative phosphorylation pathway. Conversely, the MG-associated pathway related to macrophage polarization was downregulated in MG+ AB thymoma and upregulated in MG+ B2 thymoma. We conclude that functional pathways are significantly associated with TAMG, and that some mechanisms leading to TAMG might be different among thymoma histological subtypes. Functions related to metabolisms, vascular and macrophage biology are promising new candidate mechanisms potentially involved in the pathogenesis of TAMG. More generally, the results imply that future studies addressing pathomechanisms of TAMG should take the histotype and abundance of tumor cells and non-neoplastic stromal components of thymomas into account.
胸腺瘤的一个独特特征是其与重症肌无力(MG)的极高关联频率。先前的研究报告称,MG+胸腺瘤比 MG-胸腺瘤含有更多数量的成熟“前移民”CD4+T 细胞,并且大多数胸腺瘤无论 MG 状态如何都不含有表达 AIRE 的细胞。这些发现表明,在胸腺瘤异常微环境中成熟并流出到血液中的 CD4+T 细胞对于胸腺瘤相关 MG(TAMG)的发展至关重要,而与胸腺瘤组织类型无关。然而,潜在机制仍然是个谜。为了深入了解 TAMG 的潜在机制,我们提出了三个假设:(i)具有代谢和免疫学相关性的功能途径可能在 TAMG(+)与 TAMG(-)胸腺瘤之间存在差异表达;(ii)差异富集的途径可能在幼稚淋巴细胞较少(即肿瘤细胞/基质丰富)的胸腺瘤亚组中更为明显;(iii)导致 TAMG 的机制可能在胸腺瘤组织学亚型之间有所不同。为了检验这些假设,我们使用 TCGA 数据集,分别在 AB 型和 B2 型胸腺瘤以及这些胸腺瘤类型的幼稚淋巴细胞丰富和幼稚淋巴细胞较少的亚组中,比较了与 MG 状态相关的具有潜在免疫学相关性的功能途径(=380)的表达。我们发现,与 MG-胸腺瘤相比,MG+胸腺瘤中仅有不到 10%的研究途径存在上调或下调的差异,且 AB 型和 B2 型胸腺瘤之间存在显著差异。当分析 AB 型和 B2 型胸腺瘤的上皮细胞/基质丰富亚组时,这种差异尤为明显。出乎意料的是,AB 型胸腺瘤中一些与 MG 相关的途径显著上调,而在 B2 型胸腺瘤中却显著下调,例如氧化磷酸化途径。相反,与巨噬细胞极化相关的 MG 相关途径在 MG+AB 胸腺瘤中下调,而在 MG+B2 胸腺瘤中上调。我们得出结论,功能途径与 TAMG 显著相关,并且导致 TAMG 的一些机制可能在胸腺瘤组织学亚型之间有所不同。与代谢、血管和巨噬细胞生物学相关的功能是潜在涉及 TAMG 发病机制的有前途的新候选机制。更广泛地说,这些结果意味着未来研究 TAMG 的发病机制时应考虑胸腺瘤的组织类型和肿瘤细胞以及非肿瘤性基质成分的丰度。